Clinical trial
Safety and Effectiveness of the TactiFlex SE Catheter and Volt Pulsed Field Ablation (PFA) Generator in Subjects With Paroxysmal Atrial Fibrillation
NCT06676072 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of the TactiFlex SE Catheter and Volt Pulsed Field Ablation (PFA) Generator in Subjects With Paroxysmal Atrial Fibrillation
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 22, 2024
- Completion date
- April 13, 2026
- Enrollment
- 188 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
atrial arrhythmia, atrial fibrillation (af), drug refractory paroxysmal atrial fibrillation, paroxysmal af